← Leaderboards
Michael R Knowles
University Of North Carolina Chapel Hill
$33,731,453
Attributed
$37,141,735
Total exposure
28
Grants
18
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.3M · FY2005–22$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$55,585,043 · 30
By mechanism
U54$26,689,211 · 8
R01$25,790,127 · 5
M01$2,141,477 · 15
P50$709,594 · 1
P01$254,634 · 1
Top collaborators
- Ann Harris6 shared
- Wanda K O'Neal6 shared
- Fred A. Wright4 shared
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Wanda K O'Neal$8,008,262
- Richard C Boucher$55,332,929
- Scott H Donaldson$8,054,486
Others in their field
Top investigators on “Cystic Fibrosis”
- John F Engelhardt · University Of Iowa$42,933,706
- David A Stoltz · University Of Iowa$25,455,359
- Joseph Zabner · University Of Iowa$25,382,103
- Paul B McCray · University Of Iowa$25,146,293
- Richard C Boucher · University Of North Carolina Chapel Hill$24,890,955
- Dean R Madden · Dartmouth College$23,788,969
Research focus
Cystic FibrosisClinical ResearchGenesGeneticPhenotypeMutationLung DiseasesHuman SubjectLeadDesignBaseLungGenotypeMucociliary ClearanceMolecularPrimary Ciliary DyskinesiasHereditary DiseaseSeveritiesDiagnosisNoseChronicChronic Obstructive Airway DiseaseGenetic Screening MethodDiagnostic
Grant awards (115)
Defining the Genetic Etiology of Suppurative Lung Disease in Children and Adults$511,028
U54 · FY2022 · HL · contact PI
Pathogenesis of PCD Lung Disease$619,179
R01 · FY2021 · HL · contact PI
Defining the Genetic Etiology of Suppurative Lung Disease in Children and Adults$512,984
U54 · FY2021 · HL · contact PI
Pathogenesis of PCD Lung Disease$616,952
R01 · FY2020 · HL · contact PI
Defining the Genetic Etiology of Suppurative Lung Disease in Children and Adults$515,756
U54 · FY2020 · HL · contact PI
Defining the Genetic Etiology of Suppurative Lung Disease in Children and Adults$721,258
U54 · FY2019 · HL · contact PI
Pathogenesis of PCD Lung Disease$619,285
R01 · FY2019 · HL · contact PI
Genetic Disorder of Mucocilary Clearance$1,244,095
U54 · FY2018 · HL · contact PI
Pathogenesis of PCD Lung Disease$612,031
R01 · FY2018 · HL · contact PI
Genetic Disorder of Mucocilary Clearance$65,785
U54 · FY2018 · HL · contact PI
Genetic Disorder of Mucocilary Clearance$1,244,846
U54 · FY2017 · HL · contact PI
Mining open chromatin to define molecular mechanisms of CF modifier genes$612,209
R01 · FY2017 · HL
Genetic Disorder of Mucocilary Clearance$1,242,974
U54 · FY2016 · HL · contact PI
Pathogenesis of PCD Lung Disease$438,819
R01 · FY2016 · HL · contact PI
Mining open chromatin to define molecular mechanisms of CF modifier genes$371,256
R01 · FY2016 · HL
Mining open chromatin to define molecular mechanisms of CF modifier genes$206,157
R01 · FY2016 · HL
Genetic Disorder of Mucocilary Clearance$1,245,733
U54 · FY2015 · HL · contact PI
Mining open chromatin to define molecular mechanisms of CF modifier genes$574,864
R01 · FY2015 · HL
Pathogenesis of PCD Lung Disease$432,237
R01 · FY2015 · HL · contact PI
Genetic Disorder of Mucocilary Clearance$1,249,998
U54 · FY2014 · HL · contact PI
Gene Modifiers in CF Lung Disease$735,600
R01 · FY2014 · HL · contact PI
Mining open chromatin to define molecular mechanisms of CF modifier genes$577,852
R01 · FY2014 · HL
Pathogenesis of PCD Lung Disease$430,043
R01 · FY2014 · HL · contact PI
Genetic Disorder of Mucocilary Clearance$1,190,000
U54 · FY2013 · HL · contact PI
Gene Modifiers in CF Lung Disease$714,582
R01 · FY2013 · HL · contact PI
Mining open chromatin to define molecular mechanisms of CF modifier genes$578,666
R01 · FY2013 · HL
Pathogenesis of PCD Lung Disease$417,755
R01 · FY2013 · HL · contact PI
Genetic Disorder of Mucocilary Clearance$1,250,000
U54 · FY2012 · HL · contact PI
Gene Modifiers in CF Lung Disease$750,612
R01 · FY2012 · HL · contact PI
Pathogenesis of PCD Lung Disease$386,927
R01 · FY2012 · HL · contact PI
Genetic Disorder of Mucocilary Clearance$1,225,000
U54 · FY2011 · HL · contact PI
Molecular Phenotypes for Cystic Fibrosis Lung Disease$714,831
R01 · FY2011 · HL · contact PI
Pathogenesis of PCD Lung Disease$386,927
R01 · FY2011 · HL · contact PI
Genetic Disorder of Mucocilary Clearance$1,250,000
U54 · FY2010 · HL · contact PI
Molecular Phenotypes for Cystic Fibrosis Lung Disease$722,051
R01 · FY2010 · HL · contact PI
Gene Modifiers in CF Lung Disease$706,901
R01 · FY2010 · HL · contact PI
Pathogenesis of PCD Lung Disease$390,836
R01 · FY2010 · HL · contact PI
Genetic Disorder of Mucocilary Clearance$1,250,000
U54 · FY2009 · HL · contact PI
Molecular Phenotypes for Cystic Fibrosis Lung Disease$730,049
R01 · FY2009 · HL · contact PI
Gene Modifiers in CF Lung Disease$721,005
R01 · FY2009 · HL · contact PI
Pathogenesis of PCD Lung Disease$390,490
R01 · FY2009 · HL · contact PI
GENETIC DISORDERS OF MUCOCILIARY CLEARANCE: RARE DISEASES: PCD, CF, & PHA$1,112,150
U54 · FY2008 · RR · contact PI
Genetic Disorders of Mucociliary Clearance$1,112,150
U54 · FY2008 · RR · contact PI
Molecular Phenotypes for Cystic Fibrosis Lung Disease$758,962
R01 · FY2008 · HL · contact PI
Gene Modifiers in CF Lung Disease$702,547
R01 · FY2008 · HL · contact PI
Genetic Modifiers of CF Liver Disease$614,590
R01 · FY2008 · DK · contact PI
ASSOCIATION OF GENOTYPE AND CIRCULATING LEVELS OF TGF?1 IN CYSTIC FIBROSIS PA$10,177
M01 · FY2008 · RR · contact PI
RARE GENETIC DISORDERS OF THE AIRWAYS$8,570
M01 · FY2008 · RR · contact PI
GENETIC MUTATIONS IN PATIENTS WITH PRIMARY CILIARY DYSKINESIA AND FAMILY$76
M01 · FY2008 · RR · contact PI
Genetic Disorders of Mucociliary Clearance$1,185,227
U54 · FY2007 · RR · contact PI
GENETIC DISORDERS OF MUCOCILIARY CLEARANCE: RARE DISEASES: PCD, CF, & PHA$1,185,227
U54 · FY2007 · RR · contact PI
Gene Modifiers in CF Lung Disease$716,630
R01 · FY2007 · HL · contact PI
Genetic Modifiers of CF Liver Disease$627,428
R01 · FY2007 · DK · contact PI
Pathogenesis of PCD Lung Disease$374,626
R01 · FY2007 · HL · contact PI
RARE GENETIC DISORDERS OF THE AIRWAYS$10,879
M01 · FY2007 · RR · contact PI
GENETIC MUTATIONS IN PATIENTS WITH PRIMARY CILIARY DYSKINESIA AND FAMILY$5,252
M01 · FY2007 · RR · contact PI
GENE MODIFIERS IN CYSTIC FIBROSIS LUNG DISEASE$2,064
M01 · FY2007 · RR · contact PI
MEASUREMENT OF AIRWAY TRANSEPITHELIAL POTENTIAL DIFFERENCE IN CF$938
M01 · FY2007 · RR · contact PI
GENETIC MODIFIERS OF INHERITED LIVER DISEASE$187
M01 · FY2007 · RR · contact PI
Genetic Disorders of Mucociliary Clearance$1,187,500
U54 · FY2006 · RR · contact PI
GENETIC DISORDERS OF MUCOCILIARY CLEARANCE: RARE DISEASES: PCD, CF, & PHA$1,187,500
U54 · FY2006 · RR · contact PI
Gene Modifiers in CF Lung Disease$749,372
R01 · FY2006 · HL · contact PI
Genetic Modifiers of CF Liver Disease$646,462
R01 · FY2006 · DK · contact PI
Pathogenesis of PCD Lung Disease$376,306
R01 · FY2006 · HL · contact PI
GENETIC MUTATIONS IN PATIENTS WITH PRIMARY CILIARY DYSKINESIA AND FAMILY$15,363
M01 · FY2006 · RR · contact PI
MEASUREMENT OF AIRWAY TRANSEPITHELIAL POTENTIAL DIFFERENCE IN CF$248
M01 · FY2006 · RR · contact PI
GENETIC DISORDERS OF MUCOCILIARY CLEARANCE: RARE DISEASES: PCD, CF, &PHA$1,250,000
U54 · FY2005 · RR
Genetic Disorders of Mucociliary Clearance$1,250,000
U54 · FY2005 · RR
Gene Modifiers in CF Lung Disease$738,342
R01 · FY2005 · HL
Genetic Modifiers of CF Liver Disease$646,822
R01 · FY2005 · DK
Pathogenesis of PCD Lung Disease$375,896
R01 · FY2005 · HL
GENETIC MUTATIONS IN PATIENTS WITH PRIMARY CILIARY DYSKINESIA AND FAMILY$41,782
M01 · FY2005 · RR
MEASUREMENT OF AIRWAY TRANSEPITHELIAL POTENTIAL DIFFERENCE IN CF$5,341
M01 · FY2005 · RR
GENETIC DISORDERS OF MUCOCILIARY CLEARANCE: RARE DISEASES: PCD, CF, &PHA$1,250,000
U54 · FY2004 · RR
Genetic Disorders of Mucociliary Clearance$1,250,000
U54 · FY2004 · RR
Gene Modifiers in CF Lung Disease$738,908
R01 · FY2004 · HL
Genetic Modifiers of CF Liver Disease$666,483
R01 · FY2004 · DK
Pathogenesis of PCD Lung Disease$366,717
R01 · FY2004 · HL
Genetic Mutations in Patients with Primary Ciliary Dyskinesia and Family$12,453
M01 · FY2004 · RR
Gene Modifiers in CF Lung Disease$739,103
R01 · FY2003 · HL
Gene Modifiers in CF Lung Disease$739,776
R01 · FY2002 · HL
AIRWAY SURFACE LIQUID COMPOSITION OF HUMANS IN VIVO$243,516
P50 · FY2002 · HL
MULTICENTER STUDY OF NONTUBERCULOUS MYCOBACTERIA IN PTS WITH CYSTIC FIBROSIS$190,747
M01 · FY2002 · RR
AIRWAY INFLAMMATION &MEDIATORS IN CHRONIC BRONCHITIS$190,747
M01 · FY2002 · RR
MEASUREMENT OF AIRWAY TRANSEPITHELIAL POTENTIAL DIFFERENCE IN CYSTIC FIBROSIS$190,747
M01 · FY2002 · RR
Gene Modifiers in CF Lung Disease$753,041
R01 · FY2001 · HL
MULTICENTER STUDY OF NONTUBERCULOUS MYCOBACTERIA IN PTS WITH CYSTIC FIBROSIS$294,555
M01 · FY2001 · RR
MEASUREMENT OF AIRWAY TRANSEPITHELIAL POTENTIAL DIFFERENCE IN CYSTIC FIBROSIS$294,555
M01 · FY2001 · RR
AIRWAY INFLAMMATION &MEDIATORS IN CHRONIC BRONCHITIS$294,555
M01 · FY2001 · RR
AIRWAY SURFACE LIQUID COMPOSITION OF HUMANS IN VIVO$243,516
P50 · FY2001 · HL
MEASUREMENT OF AIRWAY TRANSEPITHELIAL POTENTIAL DIFFERENCE IN CYSTIC FIBROSIS$190,747
M01 · FY2001 · RR
AIRWAY INFLAMMATION &MEDIATORS IN CHRONIC BRONCHITIS$190,747
M01 · FY2001 · RR
MULTICENTER STUDY OF NONTUBERCULOUS MYCOBACTERIA IN PTS WITH CYSTIC FIBROSIS$190,747
M01 · FY2001 · RR
HUMAN RESPIRATORY EPITHELIAL FUNCTION IN VIVO$254,634
P01 · FY2000 · HL
AIRWAY SURFACE LIQUID COMPOSITION OF HUMANS IN VIVO$222,562
P50 · FY2000 · HL
AIRWAY INFLAMMATION &MEDIATORS IN CHRONIC BRONCHITIS$0
M01 · FY2000 · RR
AIRWAY INFLAMMATION &MEDIATORS IN CHRONIC BRONCHITIS$0
M01 · FY2000 · RR
AIRWAY INFLAMMATION &MEDIATORS IN CHRONIC BRONCHITIS$0
M01 · FY2000 · RR
NONTUBERCULOUS MYCOBACTERIA IN PTS W/ CYSTIC FIBROSIS$0
M01 · FY2000 · RR
NONTUBERCULOUS MYCOBACTERIA IN PTS W/ CYSTIC FIBROSIS$0
M01 · FY2000 · RR
NONTUBERCULOUS MYCOBACTERIA IN PTS W/ CYSTIC FIBROSIS$0
M01 · FY2000 · RR
NONTUBERCULOUS MYCOBACTERIA IN PTS W/ CYSTIC FIBROSIS$0
M01 · FY2000 · RR
AIRWAY TRANSEPITHELIAL POTENTIAL DIFFERENCE IN CF$0
M01 · FY2000 · RR
AIRWAY TRANSEPITHELIAL POTENTIAL DIFFERENCE IN CF$0
M01 · FY2000 · RR
AIRWAY TRANSEPITHELIAL POTENTIAL DIFFERENCE IN CF$0
M01 · FY2000 · RR
AIRWAY TRANSEPITHELIAL POTENTIAL DIFFERENCE IN CF$0
M01 · FY2000 · RR
CPX IN ADULT W/ MILD TO MODERATELY SEVERE CYSTIC FIBROSIS$0
M01 · FY2000 · RR
CPX IN ADULT W/ MILD TO MODERATELY SEVERE CYSTIC FIBROSIS$0
M01 · FY2000 · RR
CPX IN ADULT W/ MILD TO MODERATELY SEVERE CYSTIC FIBROSIS$0
M01 · FY2000 · RR
CPX IN ADULT W/ MILD TO MODERATELY SEVERE CYSTIC FIBROSIS$0
M01 · FY2000 · RR
GLUCOCORTICOIDS &MINERALOCORTICOIDS ON ELECTRICAL POTENTIAL DIFFERENCE$0
M01 · FY2000 · RR
GLUCOCORTICOIDS &MINERALOCORTICOIDS ON ELECTRICAL POTENTIAL DIFFERENCE$0
M01 · FY2000 · RR
GLUCOCORTICOIDS &MINERALOCORTICOIDS ON ELECTRICAL POTENTIAL DIFFERENCE$0
M01 · FY2000 · RR
GLUCOCORTICOIDS &MINERALOCORTICOIDS ON ELECTRICAL POTENTIAL DIFFERENCE$0
M01 · FY2000 · RR
AIRWAY INFLAMMATION &MEDIATORS IN CHRONIC BRONCHITIS$0
M01 · FY2000 · RR